CA
SNY icon

Cullinan Associates’s Sanofi SNY Stock Holding History

Cullinan Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-98,900
Closed -$4.32M – 183
2020
Q1 		$4.32M Sell
98,900
-5,800
-6% -$278K 0.35% 75
2019
Q4 		$5.26M Buy
104,700
+6,650
+7% +$312K 0.35% 79
2019
Q3 		$4.54M Buy
98,050
+7,225
+8% +$312K 0.32% 80
2019
Q2 		$3.93M Buy
90,825
+4,650
+5% +$198K 0.29% 86
2019
Q1 		$3.82M Buy
86,175
+9,675
+13% +$414K 0.29% 91
2018
Q4 		$3.32M Sell
76,500
-4,300
-5% -$190K 0.27% 90
2018
Q3 		$3.61M Sell
80,800
-6,250
-7% -$267K 0.26% 96
2018
Q2 		$3.48M Sell
87,050
-3,600
-4% -$142K 0.27% 94
2018
Q1 		$3.63M Sell
90,650
-500
-0.5% -$20.8K 0.28% 93
2017
Q4 		$3.92M Buy
91,150
+11,950
+15% +$551K 0.29% 91
2017
Q3 		$3.94M Buy
79,200
+7,300
+10% +$353K 0.3% 85
2017
Q2 		$3.44M Buy
71,900
+7,900
+12% +$378K 0.27% 92
2017
Q1 		$2.9M Buy
64,000
+3,340
+6% +$142K 0.24% 100
2016
Q4 		$2.45M Buy
+60,660
New +$2.39M 0.21% 109

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Cullinan Associates's SNY Position: Q2 2020 in Review

Cullinan Associates sold out of Sanofi (SNY) in Q2 2020, closing a stake of 98,900 shares — an estimated $4.32M sold.

Cullinan Associates first reported a position in SNY in Q4 2016 and held it in 14 quarters. The position peaked at $5.26M in Q4 2019. 583 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

  • Cullinan Associates reported no remaining Sanofi position as of Q2 2020 after selling out during the quarter.
  • Cullinan Associates sold 98,900 Sanofi shares in Q2 2020, an estimated $4.32M.
  • Cullinan Associates first reported a position in Sanofi in Q4 2016 and held it in 14 quarters.
  • Cullinan Associates's Sanofi position peaked at $5.26M in Q4 2019.
  • 583 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.